CID 355584

N-(2-ethyl-3-methyl-1-phenyl-3-pyrazolin-5-ylidene)salicylamide

Structural Information

Molecular Formula
C19H19N3O2
SMILES
CCN1C(=CC(=NC(=O)C2=CC=CC=C2O)N1C3=CC=CC=C3)C
InChI
InChI=1S/C19H19N3O2/c1-3-21-14(2)13-18(22(21)15-9-5-4-6-10-15)20-19(24)16-11-7-8-12-17(16)23/h4-13,23H,3H2,1-2H3
InChIKey
VNCOWZFHARHZND-UHFFFAOYSA-N
Compound name
N-(1-ethyl-5-methyl-2-phenylpyrazol-3-ylidene)-2-hydroxybenzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

321.14774 Da
Monoisotopic Mass

4.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 322.15502 176.2
[M+Na]+ 344.13696 184.8
[M-H]- 320.14046 184.3
[M+NH4]+ 339.18156 189.3
[M+K]+ 360.11090 179.4
[M+H-H2O]+ 304.14500 166.3
[M+HCOO]- 366.14594 199.2
[M+CH3COO]- 380.16159 209.8
[M+Na-2H]- 342.12241 177.8
[M]+ 321.14719 177.8
[M]- 321.14829 177.8
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.